A client receives irinotecan. Classify each finding by the medication-safety decision it supports.
Matrix
Choose your responses, then check the answer.
Explanation
Diarrhea with sweating, cramping, and lacrimation during infusion is an early cholinergic pattern; diarrhea beginning more than 24 hours later is late toxicity; dehydration, fever, ileus, or neutropenia requires urgent escalation.
Quick answer Distinguish early cholinergic symptoms, late diarrhea, and high-risk complications.
Why this is correct Early symptoms may respond to authorized atropine, while late diarrhea requires prompt antidiarrheal therapy, fluid and electrolyte support, and escalation for fever, ileus, or severe neutropenia.
Easy analogy or mental picture Use a closed medication-safety loop: identify the exposure, connect the new findings, interrupt further harm, support physiology, and verify the response over time.
Memory hook Exposure, interaction, toxicity pattern, immediate action, serial reassessment.
NCLEX decision rule Choose the action that reduces the most immediate medication-related risk while preserving monitoring and escalation.
Why the other choices are wrong Options that continue the exposure, treat only one symptom, or delay reassessment leave the toxic process active.
References
1DailyMed: Irinotecan Hydrochloride InjectionEarly cholinergic diarrhea, late potentially life-threatening diarrhea, atropine, loperamide, fluids, and escalation
Medication safety reviewVerify the indication, route, interacting medicines, current respiratory and gastrointestinal findings, authorized action, and measurable follow-up.